Genmab A (GMAB) Change in Inventory (2023 - 2026)
Genmab A's (GMAB) quarterly Change in Inventory came in at -$3.0 million in Q1 2026, little changed YoY from -$3.0 million in Q1 2025, and up 40.0% on a QoQ basis from -$5.0 million in Q3 2025.
Genmab A (GMAB) Change in Inventory (2023 - 2026) Analysis & Trends
Genmab A (GMAB) has 4 years of Change in Inventory data on file, last reported at -$3.0 million in Q1 2026.
- Quarterly Change in Inventory changed 0.0% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.0 million (down 400.0% YoY) and the FY2025 annual result came in at -$9.0 million, down 800.0% from the prior year.
- Change in Inventory climbed to -$3.0 million in Q1 2026, from -$5.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $3.0 million in Q2 2024 to a low of -$8.0 million in Q4 2023.
- A 4-year average of -$3.3 million and a median of -$3.0 million in 2025 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2024 — Change in Inventory surged 87.5% — and 2025, when it sank 233.33%.
- Tracing GMAB's Change in Inventory over 4 years: stood at -$8.0 million in 2023, then surged by 87.5% to -$1.0 million in 2024, then plunged by 400.0% to -$5.0 million in 2025, then jumped by 40.0% to -$3.0 million in 2026.
- The last three Change in Inventory figures came in at -$3.0 million (Q1 2026), -$5.0 million (Q3 2025), and -$4.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Genmab A | 2.05 Bn | 548.77 Mn | 1.07 Bn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | -7.00 Mn |
| Mar 31, 2024 | -7.00 Mn |
| Dec 31, 2023 | -8.00 Mn |
| Dec 31, 2023 | -8.00 Mn |